CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan Meeting Abstract


Authors: Lunning, M. A.; Chiu, A.; Feldstein, J. T.; Maragulia, J. C.; Moskowitz, A.; Matasar, M. J.; Straus, D. J.; Noy, A.; Myskowski, P. L.; Zelenetz, A. D.; Horwitz, S. M.
Abstract Title: CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan
Meeting Title: 54th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 120
Issue: 21
Meeting Dates: 2012 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2012-11-01
Language: English
ACCESSION: WOS:000313838903087
PROVIDER: wos
DOI: 10.1182/blood.V120.21.2706.2706
Notes: --- - Meeting Abstract: 2706 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    351 Noy
  2. Julie T Feldstein
    297 Feldstein
  3. Matthew Alexander Lunning
    31 Lunning
  4. Steven M Horwitz
    645 Horwitz
  5. Andrew D Zelenetz
    767 Zelenetz
  6. Alison Moskowitz
    339 Moskowitz
  7. Matthew J Matasar
    289 Matasar
  8. David J Straus
    356 Straus
  9. Patricia Myskowski
    216 Myskowski
  10. Jocelyn C Migliacci
    104 Migliacci
  11. April Chiu
    57 Chiu